Use Of Imatinib Mesylate In Patients With Cml In Chronic Phase Resistant To Interferon-Alfa: Factors Defined At Start Of Therapy That Predict Disease Progression And Survival.D Marin, S Marktel,S O'Brien, E Olavarria,J Apperley,J GoldmanBLOOD（2002）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
